Australian drugmaker Sirtex sees getting approval for China's buyout

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Sirtex, Australia's liver cancer treatment manufacturer, is expecting its $1.4B buyout by China's consortium to win the regulatory approval in the United States and Australia, despite some diplomatic tensions.
Back to articles

Actual Topics

Fri, 15 Jun 2018 06:06:07 GMT

Apollo delays sale of security company Constellis

Apollo Global Management has suspended its plans for a sale of the US military security company Constellis, following a failure in the negotiations with the Canada Garda World Security.

Fri, 15 Jun 2018 05:15:02 GMT

RBA: asset valuation justified with low interest rates

The Assistant Governor to the Reserve Bank of Australia Luci Ellis said asset valuation was justified with the current environment of low interest rates and bond prices.

Subscribe to "Fundamental Analysis" feed

Souscrire
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.